Venus Remedies has announced that in a development crucial to improving healthcare outcomes in Latin America, leading pharmaceutical company Venus has been awarded an oncology tender by the WHO-backed Pan American Health Organisation (PAHO), the world's oldest international public health agency, for supplying essential cancer drugs to multiple Latin American countries.

This achievement signifies a major milestone for Venus Remedies, enhancing its contribution to global health initiatives and reinforcing its commitment to improving global health outcomes by providing life-saving medicines to those who need them the most.

The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs like bleomycin, carboplatin, cisplatin, cytarabine, doxorubicin, irinotecan, methotrexate, and vincristine.

This tender award highlights Venus Remedies' commitment to advancing healthcare and its crucial role in the global battle against cancer.